SHREWSBURY STEPHEN B 4
4 · IMPEL NEUROPHARMA INC · Filed Jan 28, 2022
Insider Transaction Report
Form 4
SHREWSBURY STEPHEN B
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-26+30,000→ 30,000 totalExercise: $9.85Exp: 2032-01-25→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares on February 26, 2022 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on January 26, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.